Subscribe
16 December 2016

Life Sciences Patents Network Europe 2016: Video interview with Ednaldo Silva, RoyaltyStat

At the Life Sciences Patents Network Europe 2016, a conference hosted in London last week by LSIPR, Ednaldo Silva of RoyaltyStat discusses IP licensing in the life sciences industry.

Coming from an economic background, Silva discusses the anxiety of migrating IP to an intangible holding company.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk




Editor's picks

Americas
Bernie Sanders blasts big pharma for ‘ripping off’ patients
8 February 2024

Editor's picks

Americas
Bernie Sanders blasts big pharma for ‘ripping off’ patients
8 February 2024
Americas
Pfizer and BioNTech allege inconsistencies in Moderna’s COVID-19 statements
1 February 2024
Biotechnology
Force pharma companies to provide drugs for rare cancer trials, UK govt told
30 January 2024
Biotechnology
USPTO hands win to Daiichi Sankyo in cancer drug dispute
18 January 2024
Americas
SCOTUS urged to remedy ‘threat’ to patent law in sleep drug feud
16 January 2024
Big Pharma
SCOTUS rejects big pharma’s challenge to USPTO power
9 January 2024

More features

US agency warns 10 pharma companies of filing ‘bogus’ patents
BioNTech’s patent juggling act: protecting innovation amid IP challenges
USPTO veteran joins Finnegan as of counsel in Washington, DC
CureVac and Acuitas wind up COVID-19 vaccine dispute
Amgen and Sandoz settle dispute over blockbuster bone condition drugs
GSK: Pfizer, BioNTech ‘reaped billions of dollars’ from stealing COVID-19 patents
GSK settles HIV drug licensing dispute
Meeting the cell and gene therapy scale-up challenge